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Purpose: With the recent emergence of carotid stenting in the management of carotid disease, the role of surgery has been
challenged, particularly for recurrent carotid stenosis. This study was undertaken to determine the safety and durability
of redo carotid operation (RCO) for recurrent stenosis.
Methods: A retrospective review identified 64 consecutive patients who underwent 66 RCOs between 1990 and 2000.
There were 33 males (52%) and 31 females, with a mean age of 68.2 years (range, 38-84 years). The mean interval from
the primary carotid surgery to RCO was 77.5 months (range, 1-292 months). Operative indications were severe
asymptomatic stenosis in 33 cases (50%), transient ischemic attacks (TIA) or amaurosis fugax in 25 (38%), recent stroke
in 6 (9%), and nonhemispheric symptoms in 1. Two operations were tertiary carotid reconstructions. A total of 56 (85%)
patch angioplasties were performed, 49 with vein and 6 with synthetic material. Primary closure was performed in three
cases (5%), whereas interposition grafts were required in eight (12%). Complete follow-up was available in 59 patients
(92%) and averaged 4.3 years (range, 0.2-12.9 years); 97% of patients underwent follow-up duplex scanning.
Results: There were no operative deaths and only two operative strokes (3.1%). Permanent cranial nerve deficit occurred
in one patient (1.5%). Late stroke occurred in five patients: four ipsilateral and one contralateral. Kaplan-Meier estimates
for 5- and 10-year stroke-free survival were 92% and 74%, and for overall survival were 72% and 50%. Duplex scanning
detected significant recurrent carotid stenosis (>80%) or occlusion in six cases (9%) at a mean follow-up of 4.1 years.
Kaplan-Meier estimates for freedom from recurrent stenosis of >80% were 94% and 86% at 5 and 10 years.
Conclusions: RCO for recurrent carotid stenosis can be performed safely with excellent protection from stroke and
long-term durability. These data provide a standard against which the results of carotid stenting can be compared. (J
Vasc Surg 2004;39:155-61.)
No surgical procedure has endured more intense scru-
tiny than carotid endarterectomy (CEA). Through multi-
ple randomized trials for symptomatic1-3 and asymptomat-
ic4-6 carotid stenosis, CEA has been proven to be an
effective and durable procedure to reduce the risk of stroke.
With the recent emergence of carotid angioplasty and
stenting (CAS) as a safe alternative to CEA7-12 clinical
equipoise between CAS and CEA now exists among differ-
ent specialists. As a result, the role of CEA is again being
challenged, in particular for high-risk patients or for those
with recurrent carotid stenosis (RCS). Long-term results
after CAS are scarce and, when available, will need to be
compared with those of CEA to help resolve uncertainty
about its role. Although the literature is replete with papers
on RCS, long-term outcome after redo carotid operation
(RCO) with objective documentation of carotid artery
patency is relatively scarce.13-16 This study was undertaken
to review a contemporary series of patients undergoing
RCOs to define the safety and durability of such proce-
dures.
METHODS
From a computerized vascular surgery registry and
institutional operative logs, all patients who underwent
CEA on the vascular surgery service at the Henry Ford
Hospital between January 1990 and December 2000 were
identified. Of the 1127 consecutive CEAs performed dur-
ing this period, 66 RCOs were carried out in 64 patients,
representing 6% of the total. Two of these patients, who
had had a secondary RCO performed elsewhere, under-
went a tertiary carotid reconstruction. Individual RCOs
were counted separately so that patients undergoing
staged, bilateral procedures were recorded and evaluated as
two entries. Specifically excluded were patients who under-
went re-exploration in the immediate postoperative period
for lesions related to technical problems, such as clamp
injuries, intimal flaps, or kinks.
The specific end points analyzed were 30-day death,
stroke, and other procedure-related complications and the
occurrence of late stroke, death, and secondary restenosis.
Stroke was defined as any focal neurologic deficit of abrupt
onset persisting for more than 24 hours. Incidence rates for
late death, stroke, and carotid artery secondary restenosis
were studied. Perioperative morbidity and mortality, as well
as 5-year stroke-free survival and 5-year survival rates, were
compared with those of primary CEAs performed during
the same period.17 Follow-up data were obtained through
review of medical records and clinic notes or by direct
contact with the patient or family. Records of carotid
duplex scans were retrieved from a computerized vascular
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laboratory registry. Our noninvasive vascular laboratory
grades the degree of carotid stenosis on the basis of the
classic categories defined by the University of Washington
vascular laboratory in the early 1980s and updated in the
1990s.18 The following categories were used: 0%-15%,
16%-49%, 50%-59%, 60%-79%, 80%-99%, and occlusion.
Because secondary restenosis is likely to occur before its
detection, the time of secondary restenosis was chosen to
be the midpoint between the last normal examination
(50% stenosis) and its detection.
Sociodemographic data and risk factors associated with
perioperative morbidity and mortality were evaluated by
using 2 and the Student t-test as appropriate. Cox propor-
tional hazard model was used for relative risk determination
for data with variable follow-up. Actuarial survival analysis
was performed by using Kaplan-Meier life tables. A P value
of 0.05 (log-rank) was considered significant for all sta-
tistical analyses.
RESULTS
The study population included 33 males (52%) and 31
females, with a mean age of 68.2 years (range, 38-84 years).
Comorbidities are listed in Table I. No differences were
noted in the distribution of risk factors between symptom-
free patients and those with symptoms. When compared
with 1045 primary CEAs performed at the Henry Ford
Hospital from January 1990 to December 1999,17 no
significant differences were detected in the incidence of risk
factors.
Operative indications were severe asymptomatic steno-
sis detected on routine follow-up duplex examinations in
34 cases (52%), TIAs or amaurosis fugax in 25 cases (38%),
recent stroke in 6 cases (9%), and nonhemispheric symp-
toms in 1 case. Among the symptom-free patients, 31
(91%) were found to have a stenosis of greater than 80% on
duplex imaging. The remaining three patients with less
than 80% recurrent stenosis underwent RCO for 60%-79%
stenosis with either an ulcerated lesion (two patients) or
kinking of the internal carotid artery (one patient). The
mean interval from the primary carotid surgery to RCO was
6.6 years (range, 0.2-24.7 years). Thirty-five percent of
patients underwent RCO within 18 months of their pri-
mary CEA.
All RCOs were performed under general anesthesia,
with continuous electroencephalographic (EEG) monitor-
ing in 94% of the patients. Intraoperative shunting was used
in 27% of the cases (17 of 62), on the basis of EEG changes.
Arteriotomies were closed predominantly with patch an-
gioplasty in 55 cases (85%): 49 with vein and 6 with
Dacron. Primary closure was performed in 3 cases (5%),
whereas interposition grafts were required in 8 cases (12%):
7 with vein and 1 with expanded polytetrafluoroethylene.
Mandibular subluxation was employed in 11 cases
(17%), with resection of the styloid process to expose a
high, distal lesion in one patient. The contralateral ICA was
occluded in eight patients (12%) and the ipsilateral ICA was
occluded in two patients (3%), one of whom underwent
endarterectomy of external carotid artery for amaurosis
fugax, and the other for an upper extremity weakness. The
pathology of recurrent stenosis was available in 55 cases
(83%). RCOs were performed for neointimal hyperplasia in
18 patients at a mean of 1.3 years (range, 0.3-4.1 years)
after the primary CEAs and for recurrent atherosclerosis in
33 patients at a mean of 7.8 years (range, 0.8-24.8 years).
Four patients were found to have combined atherosclerotic
and neointimal hyperplastic changes on gross examination
of plaques at a mean of 1.9 years (range, 0.2-6.8 years). Of
those with neointimal hyperplasia, four patients (25%) had
symptoms at the time of RCO; 61% of those with recurrent
atherosclerosis were symptom-free. The neointimal hyper-
plasia was treated by redo endarterectomy and patch angio-
Table II. Complications





Partial transection of CN XII 1 (1.5)
Permanent vocal cord paralysis 1 (1.5)
Transient CN X palsy 1 (1.5)
Transient CN XI palsy 1 (1.5)
Transient mandibular nerve palsy 2 (3)
Brachial artery thrombosis 1 (1.5)
Hematoma requiring evacuation 2 (3)
A patient may have more than one complication.
TIA, Transient ischemic attacks; CN, cranial nerve.
Table III. Comparison of perioperative complications
between RCO and primary CEA
RCO (%) 1° CEA (%) P
Stroke 3 3 .99
Death 0 0.9 .5
TIA 3 0.5 .02
CN injury 6 2.5 .08
Cervical hematoma 3 1.7 .6
MI 3 1.1 .2
Death, stroke, TIA 6 4 .5
Death, stroke, TIA, MI 9 5 .2
TIA, CN injury, cervical hematoma 12 5 .01
All combined 18 10 .03
RCO, Redo carotid operation; 1° CEA, primary carotid endarterectomy;
TIA, transient ischemic attack; CN, cranial nerve; MI, myocardial infarction.
Table I. Comorbidities




Heart disease 35 (54)
DM 16 (25)
Renal insufficiency 5 (8)
HTN, Hypertension; DM, diabetes mellitus.
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Fig 1. Kaplan-Meier estimates for overall survival (A) and survival stratified by symptom status (B) at the time of redo
carotid operation. Shaded areas in curves represent SE.
Fig 2. Kaplan-Meier estimates for ipsilateral stroke-free survival (A) stratified by symptom status (B) at the time of redo
carotid operation. Shaded areas in curves represent SE.
Fig 3. Kaplan-Meier estimates for freedom from recurrent stenosis of80% (A) stratified by symptom status (B) at the
time of redo carotid operation. Shaded areas in curves represent SE.
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plasty in all but four patients, who underwent interposition
grafting.
There were no operative deaths and two operative
strokes (3%): one ipsilateral and one contralateral. Overall,
16 complications occurred in 13 patients (Table II). Peri-
operative TIAs were noted in two patients. Myocardial
infarction occurred in two patients (3%), requiring coro-
nary artery bypass grafting in one patient. Major cranial
nerve injuries occurred in four patients (6%), in two of
whom mandibular subluxation was employed for distal
exposure. A partial severance of the hypoglossal nerve was
recognized and repaired intraoperatively in one patient; he
did not manifest any clinical deficit postoperatively. One
patient suffered a permanent vocal fold paralysis. A tran-
sient spinal accessory nerve palsy occurred in one patient,
who required mandibular subluxation and resection of the
styloid process for access to a high, distal lesion; her symp-
toms resolved after 5 months. A recurrent laryngeal nerve
palsy occurred in another patient with mandibular sublux-
ation; she regained full mobility of her vocal folds after 8
months. Two patients had transient marginal mandibular
branch nerve palsy. Cervical wound hematoma requiring
operative drainage developed in two patients (3%). One
patient required a brachial artery thrombectomy for prob-
lems related to an arterial line. The overall perioperative
complication rate was higher when compared with those
for primary CEA (Table III), primarily because of an in-
creased incidence of cranial nerve injury and TIA.
Comparison of comorbidity analysis for RCO with the
authors’ experience for primary CEA17 failed to demon-
strate any traditional risk factor that was associated with
RCO; smoking was the only factor that showed a trend
towards statistical significance (P  .06).
Follow-up data were available on 59 patients (89%) and
ranged from 0.2 to 12.9 years, with a mean of 4.3 years.
During follow-up, 20 late deaths occurred at a median of
2.0 years (range, 0.5-8.3 years). Causes of death were
cardiac in 8 patients, malignancy in 5 patients, pulmonary
in 2 patients, stroke in 1 patient, and gangrene-induced
sepsis in 1 patient. In three patients, the cause was unde-
termined. Kaplan-Meier estimates for the probability of
overall survival were 72% at 5 years and 50% at 10 years (Fig
1). The symptom status at the time of RCO had differential
effects on survival: symptom-free patients had 5- and 10-
year survival rates of 85% and 64%, compared with 56% and
29%, respectively, for patients with symptoms (P  .008;
Fig 1, B).
Late stroke occurred in five patients (8%): four ipsilat-
eral and one contralateral. One patient developed a fatal
ipsilateral stroke 4 years after her RCO. Another patient
developed an ipsilateral stroke 6 weeks after a saphenous
vein interposition grafting and was found to have severe
stenosis of the saphenous graft. To avoid the partial man-
dibulectomy that would have been required to gain access
to the lesion, a superficial temporal-to-middle cerebral
artery bypass grafting was performed without complication.
One patient developed an ipsilateral stroke 8.2 years after
RCO in the immediate postoperative period following
coronary artery bypass grafting. The duplex scan performed
at the time of the stroke revealed a secondary recurrent 60%
to 80% ICA stenosis. Follow-up duplex imaging performed
4 years later showed regression to50%. One contralateral
stroke occurred in a patient who underwent prophylactic
aortoinnominate bypass grafting 4 months after the RCO.
The probability of freedom from any stroke at 5 years was
92%, and 74% at 10 years (Fig 2, A). Again, symptom-free
patients at the time of RCO appeared to enjoy better
stroke-free survival than those who had symptoms (100% vs
84% at 5 years; P  .1). The probability of freedom from
ipsilateral stroke was 93% at 5 years and 75% at 10 years (Fig
2, A and B). Univariate analysis of comorbidities and
symptom status at the time of RCO revealed renal insuffi-
ciency (P  .03) and symptomatic presentation (P  .04)
to be significant predictors of postoperative stroke. How-
Table IV. Summary of reports on management of recurrent carotid stenosis
Author Study period
No. pts/no.
arteries Indications Stroke TIA Death
Ballinger44 1/84-8/95 67/74 Sx 65% 1.4% NA 1.4%
Asx 35%
Rockman13 1/80-12/96 74/83 Sx 41.5% 3.7% NA 0
Asx 35.3%
Archie14 1/81-12/99 66/69 Sx 48% 1.4% 1.4% 0
Asx 52%
AbuRahma15 10/91-10/98 124/124 Sx 78% 4.8% 4% 0
Asx 22%
O’Hara16 1/89-12/99 199/206 Sx 43% 3.4% NA 1.0%
Asx 57%
Hill19 9/93-3/98 40/40 Sx 50% 0% 0% 0
Asx 50%
Mansour25 8/76-8/96 69/82 Sx 66% 4.8% 1% 0
Asx 34%
Current series 1/90-12/2000 64/66 Sx 48% 3% 3% 0
Asx 52%
TIA, Transient ischemic attack; MI, myocardial infarction; Sx, symptomatic; Asx, asymptomatic; NA, not available; MI, myocardial infarction.
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ever, on multivariate analysis, none of these proved to be of
significance.
Postoperative duplex imaging was available in 97% of
cases, of which 53% had carotid imaging beyond 18 post-
operative months (range, 1 month– to 12.1 years). Of 31
cases with carotid duplex imaging follow-up in 18
months, 16 patients died. Greater than 50% secondary
restenosis was detected in five patients (8%) at a mean of 27
months (range, 4-61 months). Of these, three patients
developed80% secondary restenosis at a mean time of 33
months, including one patient who had an asymptomatic
internal carotid artery occlusion 4 months after RCO. No
patient had symptoms develop. Kaplan-Meier estimates for
freedom from 80% secondary restenosis were 96% at 5
years and 86%, at 10 years (Fig 3, A and B). The patients’
symptom status at the time of RCO did not influence the
outcome.
DISCUSSION
This study illustrates that RCO can be performed safely
and effectively with long-term durability in the modern era.
There was no 30-day operative mortality, and the operative
stroke rate was only 3%. This is comparable to the findings
of other series (Table IV), as well as to those of the authors’
combined stroke and death rate of 3.9% for 1045 primary
CEAs performed between 1990 and 1999.17
Half of the redo carotid operations performed in this
series were in symptom-free patients. The operative indica-
tions in this series did not differ from those reported by
others.14,16,19,20 With respect to risk factors, none of the
traditional risk factors emerged to affect the incidence of
RCO; smoking was the only factor that showed a trend
toward statistical significance (P .06). Other studies have
observed that smoking was associated with RCS.21-24
Neointimal hyperplasia accounted for the vast majority
of early (18 months) recurrences, whereas atherosclerosis
was the cause for most late (18 months) recurrences,
relatively evenly distributed along the time line. Consistent
with previous reports,19,25 plaques with mixed atheroscle-
rotic and hyperplastic changes were also noted in both early
and late recurrent lesions in this series. It is also of interest
to note that a quarter of those with neointimal hyperplasia
had symptomatic presentation, which is higher than that
reported by Das et al.26 Although histologic examination of
plaques was not performed, these findings lend support to
the notion that early and late recurrent lesions are one and
the same, just observed at different time points along a
continuum.27
The cumulative survival rate at 5 years after RCO was
72% and was favorably influenced by the lack of preopera-
tive symptoms. This was comparable to our 75% 5-year
survival rate following primary CEA.17 The overall ipsilat-
eral stroke-free survival was 93% at 5 years and 75% at 10
years, consistent with the findings of others (Table IV) and
with our results for primary CEA (94% at 5 years). When
stratified by symptom status, the results of RCO for symp-
tom-free patients are comparable to those for primary
CEA17 and to those reported by the Asymptomatic Carotid
Atherosclerotic Study.6 Similarly, for patients with symp-
toms, the 5- and 9-year estimates for ipsilateral stroke-free
survival were both 84%, comparable to our primary CEA
results17 and to North American Symptomatic Carotid
Endarterectomy Trial data.1 Although statistical signifi-
cance was not achieved, symptom-free patients appeared to
enjoy a higher degree of ipsilateral stroke prevention than
did patients with symptoms. This series shows that RCO is
as effective as primary CEA is in stroke prevention.
An evaluation of the durability of RCO showed that the
probability of freedom from 80% secondary restenosis
was 96% at 5 years. These results are consistent with the
experience of other investigators (Table IV). The ACAS
and other prospective surveillance programs have reported
late recurrence rates ranging from 4.9%28 to 21% at 7





injury Mean follow-up Stroke-free survival
Freedom from
restenosis (80%)
2.8% NA 2.7% 48.2 mos 93.6% at 5 yrs (ipsilateral) NA
3.7% 0% 1.2% 35 mos 83.5% with veins; 93.9% with
prosthetics at 3 yrs
NA
2.9% 0% 4.3% 50 mos 90% at 5 yrs (cumulative)
86% at 10 yrs
88.2% at 5 yrs (50%)
4.8% 0 17% 49 mos 82% at 5 yrs (cumulative) 95% at 5 yrs (50%)
5.3% 1.0% 1.0% 47 mos 92% at 5 yrs 89% at 5 yrs
0% 2.5% 10% 14 mos NA NA
4.8% 2% 7.3% NA 92.3% at 5 yrs 92.3% at 5 yrs
3% 5% 6% 52 mos 93% at 5 yrs (ipsilateral) 96% at 5 yrs
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an ipsilateral stroke that was specifically the result of a
secondary carotid stenosis. These findings reaffirm that
RCO is a durable means of stroke prevention with compa-
rable efficacy to that of primary CEA.
An increased rate of perioperative complication was
noted in this series compared with the authors’ series of
primary CEA. Although several series have documented
that RCO can be performed with morbidity and mortality
rates similar to those of primary CEA,16,19,20 the compli-
cation rates for RCO are generally considered higher than
those for primary CEA.15,26,32,33 Cranial nerve injuries
account for the majority of these complications and have
been reported in up to 48% of cases.14,15,22,25,32,34-36
These injuries result from the fibrotic tissue reaction that
obscures the normal plane of dissection.25,32 Even though
most cranial nerve injuries are transient,15,22,25,32 they do
result in disability and may take a prolonged period of time,
often exceeding many months, for full recovery. In this
series, two of four patients with major cranial nerve injuries
required mandibular subluxation, including one patient
who had resection of the styloid process. Mandibular sub-
luxation was employed in 17% of cases when the recurrent
lesion, on preoperative arteriography, was found to be
extending beyond the second vertebral body. This rela-
tively high incidence of utilization of mandibular subluxa-
tion probably reflects the referral pattern to our institution.
Distal lesion requiring mandibular subluxation may be a
marker for potential cranial nerve injury. It is this group of
patients in whom CAS may prove most beneficial.
Early results for CAS in high-risk patients have im-
proved significantly since its introduction.7,11,37,38 Some
early trials comparing the efficacy of CEA with CAS were
terminated early because of the high incidence of adverse
events and poor short-term results in the endovascular
group.39,40 In 2000, New et al41 reported, in a retrospec-
tive review of multicenter registry on CAS performed for
recurrent stenosis in 338 patients (358 arteries), a 3.7%
periprocedural stroke and death rate.41 More recently, the
Carotid and Vertebral Artery Transluminal Angioplasty
Study trial was completed, and its results were released in
2001.42 This study showed no difference in the 30-day
combined death and stroke rates between CAS (10%) and
CEA (9.9%), whereas cranial nerve injury (9%), myocardial
infarction (1%), pulmonary embolism (1%), and respiratory
failure (1%) occurred only in the surgical arm.
Carotid stenting has been further supported by the
improved results seen with the use of a distal protection
device as in the Stenting and Angioplasty with Protection in
Patients at High Risk for Endarterectomy (SAPPHIRE)
trial. In this first US prospective randomized multicenter
trial comparing CAS with distal protection against CEA in
high-risk patients, 307 patients were randomized to either
CAS or CEA at 22 sites. The preliminary results presented
at the American Heart Association meeting in November of
2002 documented that the 30-day combined death and
stroke rate did not differ between the two groups: 4.5% for
CAS and 6.6% for CEA. However, when myocardial infarc-
tion was included in the calculation of major adverse out-
come rates, the complication rate was significantly lower in
the CAS group (5.8%) than the CEA group (12.6%). Fur-
thermore, cranial nerve injury occurred only in the CEA
group (5.3%).
Carotid stenting has been criticized because of a high
recurrent stenosis rate. Although New et al41 have reported
a 96% probability of freedom from stroke at 3 years, subse-
quent studies have shown higher recurrence rates. In the
CAVATAS trial,42 severe ipsilateral RCS was present more
frequently in the endovascular group (14%) than in the
surgical group (4%) at 1-year follow-up. However, this
difference did not translate into a difference in the rates of
death or disabling stroke at 3 years (endovascular and CEA,
14.3% and 14.2%, respectively). Roubin and colleagues43
reported an 88% probability of freedom from any stroke at
3 years in their follow-up of 604 CASs performed on 528
patients. It is noteworthy that a large proportion of the
patients in this trial were high-risk patients who would have
been ineligible for NASCET.
These early results, although limited, look promising
and success rates will likely continue to improve with ad-
vances in technology. The long-term outcome data from
prospective randomized trials will provide definitive an-
swers for both low-risk and high-risk patients. Until then,
the surgical results from modern series will serve as a
benchmark against which the efficacy and durability of
these newer modalities will be measured.
There are several limitations with this study. It has the
usual shortcoming of any retrospective study. Follow-up
was not complete in all patients—five patients were lost to
follow-up. Late neurologic events occurring outside of our
institution may have been missed. The incidence of periop-
erative neurologic adverse events might have been under-
estimated. Referral and selection bias might have affected
the outcomes.
Nonetheless, this study clearly demonstrates that RCO
can be performed with acceptable stroke and death rates
and that it is an effective means of stroke prevention in
patients with RCS. That the perioperative complications
rates for RCO are higher than those for primary CEA
should not detract from its long-term benefits. Redo ca-
rotid operation is a durable procedure with excellent long-
term patency. Careful patient selection, preoperative plan-
ning, and meticulous operative technique, including use of
bipolar cautery and nerve stimulator, should be emphasized
to minimize cardiac neurologic and other complications.
Extra caution should be taken to avoid cranial nerve injury
when mandibular subluxation is required for distal expo-
sure. Until long-term results of CAS are available, redo
carotid operation should remain the standard of treatment
for recurrent carotid stenosis.
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